Ilan Daskal
CIK 1446964 · EVP, CFO · last filed 2025-12-03
Ilan Daskal is an EVP, CFO who has filed 65 SEC Form 4 insider transactions across 7 companies since 2008. The most recent filing shows the insider sold $3.0M of VIAV on Dec 3, 2025. Across all open-market trades the lifetime net is −$10.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.92M
7
65
-$10.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIAV | EVP, CFO | 155,032 | $53.46 | $8.29M | -$3.73M | 9 | 2025-12-03 |
| BIO.B | EVP, Chief Financial Officer | 2,206 | $304.15 | $671.0K | -$2.40M | 12 | 2023-09-06 |
| NATUS MEDICAL INC (NTUS) Delisted | Director | 0 | $32.96 | $0 | -$68.7K | 6 | 2022-07-21 |
| IXIA (XXIA) Delisted | Director | 16,140 | — | — | $0 | 2 | 2016-06-07 |
| SUNE | EVP & CFO Designee | 400,000 | $2.41 | $964.0K | $0 | 1 | 2016-04-11 |
| CEPHEID (CPHD) Delisted | EVP, Chief Financial Officer | 10,000 | — | — | $0 | 1 | 2015-04-13 |
| INTERNATIONAL RECTIFIER CORP /DE/ (IRF) Delisted | Executive Vice President & CFO | 0 | — | — | -$3.88M | 33 | 2015-01-13 |
Recent Filings
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-03 | VIAV | Sell (S) | −170,000 | -$2.97M | EDGAR |
| 2025-12-01 | VIAV | Mixed | +111,145 | -$1.64M | EDGAR |
| 2025-09-25 | VIAV | Mixed | +38,729 | -$394.8K | EDGAR |
| 2025-09-02 | VIAV | Mixed | +30,258 | -$280.1K | EDGAR |
| 2025-06-06 | VIAV | Sell (S) | −82,095 | -$761.8K | EDGAR |
| 2024-12-02 | VIAV | Mixed | +82,095 | -$833.5K | EDGAR |
| 2024-09-26 | VIAV | Grant (A) | — | $0 | EDGAR |
| 2024-08-30 | VIAV | Grant (A) | — | $0 | EDGAR |
| 2023-11-30 | VIAV | Grant (A) | — | $0 | EDGAR |
| 2023-09-06 | BIO.B | Mixed | +974 | -$283.3K | EDGAR |